The Patent Finder

1,3-Butylene Glycol Product

Daicel Corporation

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 12,521,3281,3-Butylene Glycol Product
In force
 · High confidence
UsedRemaining
Daicel CorporationIn forceHigh confidence
US 12,458,5711,3-Butylene Glycol Product
In force
 · High confidence
Daicel CorporationIn forceHigh confidence
US 12,728,0831,3-Butylene Glycol Product
In force
 · High confidence
Daicel CorporationIn forceHigh confidence
Application 19/364,6231,3-Butylene Glycol Product
Pending
Not granted
Daicel CorporationPendingNot granted
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Daicel Corporation.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited